Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance

Journal of Experimental Medicine

Volumn 187, Issue 7, 1998, Pages 1133-1138

  Hammerberg, Craig ^a   Katiyar, Santosh K ^a   Carroll, Michael C ^b   Cooper, Kevin D ^a,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; CD11B ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; CONTACT SENSITIVITY; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION;

ANIMALS; ANTIGENS; COMPLEMENT C3; DINITROFLUOROBENZENE; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; LEUKOCYTES; MACROPHAGE-1 ANTIGEN; MICE; PHOTOSENSITIVITY DISORDERS; RECEPTORS, COMPLEMENT 3B; SKIN PHYSIOLOGY; ULTRAVIOLET RAYS;

EID: 0032489921     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.7.1133     Document Type: Article

References (39)

1. Feldbush, T.L., M.V. Hobbs, C.D. Severson, Z.K. Ballas, and J.M. Weiler. 1984. Role of complement in the immune response. Federation Proc. 43:2548-2552.
2. Erdei, A., G. Fust, and J. Gergely. 1991. The role of C3 in the immune response. Immunol. Today. 12:332-337.
3. Lio, D., G. Sireci, F. Gervasi, F. Dieli, and A. Salerno. 1992. Induction of contact sensitivity by cell-associated immuno-complexes requires activation of the early complement components. Int. J. Exp. Path. 73:741-750.
4. Dieli, F., G. Sireci, D. Lio, and A. Salerno. 1989. Role of the fourth complement component (C4) in the regulation of contact sensitivity. Cell. Immunol. 123:236-243.
5. Tsuji, R.F., M. Kikuchi, and P.W. Askenase. 1996. Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity. J. Immunol. 156:4644-4650.
6. Dovezenski, N., R. Billetta, and I. Gigli. 1992. Expression and localization of proteins of the complement system in human skin. J. Clin. Invest. 90:2000-2012.
7. Basset-Seguin, N., S.W. Caughman, and K.B. Yancey. 1990. A-431 cells and human keratinocytes synthesize and secrete the third component of complement. J. Invest. Dermatol. 95: 621-625.
8. Yancey, K.B., O. Overholser, N. Domloge-Hultsch, L.-J. Li, S.W. Caughman, and P. Bisalbutra. 1992. Human keratinocytes and A-431 cells synthesize and secrete factor B, the major zymogen protease of the alternative complement pathway. J. Invest. Dermatol. 98:379-383.
9. Terui, T., K. Ishii, M. Ozawa, N. Tabata, T. Kato, and H. Tagami. 1997. C3 production of cultured human epidermal keratinocytes is enhanced by IFN-gamma and TNF-alpha through different pathways. J. Invest. Dermatol. 108:62-67.
10. Rauterberg, A., E.G. Jung, and E.W. Rauterberg. 1993. Complement deposits in epidermal cells after ultraviolet B exposure. Photodermatol. Photoimmunol. Photomed. 9:135-143.
11. Torinuki, W., and H. Tagami. 1986. The role of complement in UVB-induced inflammation. Acta Dermato-Venereol. 66:386-390.
12. Hammerberg, C., N. Duraiswamy, and K.D. Cooper. 1996. Reversal of immunosuppression inducible through ultraviolet-exposed skin by in vivo anti-CD11b treatment. J. Immunol. 157:5254-5261.
13. Wessels, M.R., P. Butko, M. Ma, H.B. Warren, A.L. Lage, and M.C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA. 92: 11490-11494.
14. Yeh, C.G., H.C. Marsh, Jr., G.R. Carson, L. Berman, M.F. Concino, S.M. Scesney, R.E. Kuestner, R. Skibbens, K.A. Donahue, and S.H. Ip. 1991. Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats. J. Immunol. 146:250-256.
15. Cooper, K.D., N. Duraiswamy, C. Hammerberg, E. Allen, C. Kimbrough-Green, W. Dillon, and D. Thomas. 1993. Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury. J. Invest. Dermatol. 101:155-163.
16. Learn, D.B., J. Beard, and S.J. Moloney. 1993. The ultraviolet C energy emitted from FS lamps contributes significantly to the induction of human erythema and murine ear edema. Photodermatol. Photoimmunol. Photomed. 9:147-153.
17. Hammerberg, C., N. Duraiswamy, and K.D. Cooper. 1996. Temporal correlation between UV radiation locally-inducible tolerance and the sequential appearance of dermal, then epidermal, class II MHC+ CD11b+ monocytic/macrophagic cells. J. Invest. Dermatol. 107:755-763.
18. Kalli, K.R., P. Hsu, and D.T. Fearon. 1994. Therapeutic uses of recombinant complement protein inhibitors. Springer Semin. Immunopathol. 15:417-431.
19. Pemberton, M., G. Anderson, V. Vetvicka, D.E. Justus, and G.D. Ross. 1993. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J. Immunol. 150:5104-5112.
20. Hammerberg, C., N. Duraiswamy, and K.D. Cooper. 1994. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultraviolet-exposed epidermal cells is dependent upon infiltrating class II MHC+ CD11b(bright) monocytic/ macrophagic cells. J. Immunol. 153:4915-4924.
21. Basset-Seguin, N., M. Porneuf, O. Dereure, V. Mils, A. Tesnieres, K.B. Yancey, and J.-J. Guilhou. 1993. C3d,g deposits in inflammatory skin diseases: use of psoriatic skin as a model of cutaneous inflammation. J. Invest. Dermatol. 101: 827-831.
22. Basset-Seguin, N., M. Dersookian, K. Cehrs, and K.B. Yancey. 1988. C3d,g is present in normal human epidermal basement membrane. J. Immunol. 141:1273-1280.
23. Elsner, J., M. Oppermann, W. Czech, and A. Kapp. 1994. C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins. Blood. 83:3324-3331.
24. Karp, C.L., M. Wysocka, L.M. Wahl, J.M. Ahearn, P.J. Cuomo, B. Sherry, G. Trinchieri, and D.E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science. 273:228-231.
25. Riemann, H., S. Grabbe, A. Schwarz, Y. Aragane, T.A. Luger, M. Wysocka, M. Kubin, G. Trinchieri, and T. Schwarz. 1995. In vivo application of an interleukin 12 antibody induces hapten specific tolerance. J. Invest. Dermatol. 104:571.(Abstr.)
26. Schwarz, A., S. Grabbe, H. Riemann, Y. Aragane, M. Simon, S. Manon, S. Andrade, T.A. Luger, A. Zlotnik, and T. Schwarz. 1994. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol. 103:211-216.
27. Schwarz, A., S. Grabbe, Y. Aragane, K. Sandkuhl, H. Riemann, T.A. Luger, M. Kubin, G. Trinchieri, and T. Schwarz. 1996. Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance. J. Invest. Dermatol. 106:1187-1191.
28. Riemann, H., A. Schwarz, S. Grabbe, Y. Aragane, T.A. Luger, M. Wysocka, M. Kubin, G. Trinchieri, and T. Schwarz. 1996. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J. Immunol. 156:1799-1803.
29. Katiyar, S.K., C. Hammerberg, and K.D. Cooper. 1998. Altered immunoregulatory cell and cytokine response to UV and hapten alone differ from complex combined exposure. J. Invest. Dermatol. In press. (Abstr.)
30. Fallman, M., D.P. Lew, E. Stendahl, and T. Andersson. 1989. Receptor-mediated phagocytosis in human neutrophils is associated with increased formation of inositol phosphates and diacylglycerol. J. Clin. Invest. 84:886-891.
31. Graham, I.L., D.C. Anderson, V.M. Holers, and E.J. Brown. 1994. Complement receptor 3 (CR3, Mac-1, Integrin aMb2,CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils. J. Cell. Biol. 127:1139-1147.
32. Zheng, L., A. Sjolander, J. Eckerdal, and T. Andersson. 1996. Antibody-induced engagement of b2 integrins on adherent human neutrophils triggers activation of p21ras through tyrosine phosphorylation of the protooncogene product Vav. Proc. Natl. Acad. Sci. USA. 93:8431-8436.
33. Crockett-Torabi, E., B. Sulenbarger, C.W. Smith, and J.C. Fantone. 1995. Activation of human neutrophils through L-selectin and Mac-1 molecules. J. Immunol. 154:2291-2302.
34. Cao, D., I.F. Mizukami, B.A. Garni-Wagner, A.L. Kindzelskii, R.F. Todd III, L.A. Boxer, and H.R. Petty. 1995. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. J. Immunol. 154:1817-1829.
35. Shibaki, A., and K.D. Cooper. 1994. Differential APC subset responsiveness to the extracellular milieu: Langerhans cells are resistant to calcium flux, whereas normal blood and UV-induced cutaneous macrophages respond to FMLP, FcγRI, and FC-γRII crosslinking. J. Invest. Dermatol. 102:526.(Abstr.)
36. Gadd, S.J., R. Eher, O. Majdic, and W. Knapp. 1994. Signal transduction via FcγR and Mac-1 alpha-chain in monocytes and polymorphonuclear leucocytes. Immunology. 81:611-617.
37. Marth, T., and B.L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185: 1987-1995.
38. Sutterwala, F.S., G.J. Noel, R. Clynes, and D.M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185:1977-1985.
39. Rang, K., Y. Yoshida, G. Chen, A.C. Gilliam, C. Hammerberg, and K.D. Cooper. 1998. Ligands for beta 1 and beta 2 integrins are induced in ultraviolet-exposed human skin and upregulate monocytic/macrophagic cell IL-10, but downregulate IL-12 production. J. Invest. Dermatol. In press. (Abstr.)